Daxor
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
350 5th Ave Ste 7120, New York City, New...Phone Number
(865) 425-0555Website
www.daxor.comRevenue
<$5 MillionStock Symbol
DXRIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Daxor
Founded in 1971, Daxor Corporation (NYSE: DXR) is the global leader in blood volume measurement technology focused on blood volume testing innovation.Explore more
Daxor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Daxor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Daxor has new funding data
Daxor, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Daxor recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Daxor had a recent Job posting/layoffs
Product Launch: Get notified when Daxor launches new products
Congratulate Masked Content for being promoted to Masked Content at Daxor
Check out if Daxor is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Daxor has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Daxor as Masked Content
Find more new buyers
Compare Similar Companies to Daxor
Compare insights from companies similar to Daxor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Daxor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Daxor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Daxor.
Daxor financials insights
Gather financial insights about Daxor, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Daxor Tech Stack
A closer look at the technologies used by Daxor
See more technologies
Most Recent Scoops
Person-Based
Medical Research, Clinical Operations
Person-Based
Person-Based
Product Development, Sales
Person-Based
Product Management
Person-Based
Medical Research
Daxor News & Media
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
Oak Ridge, TN, April 28, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will exhibit its Blood Volume Analyzer (BVA™) technology at the MedAxiom CV Transforum Spring’26 Conference. The event, being held at the Sawgrass Marriott Golf Resort & Spa, Ponte Vedra Beach, FL, from April 30 – May 2, 2026, is a premier venue for cardiovascular thought leaders and industry innovators to driveDaxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
Oak Ridge, TN, April 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, continues its strategic expansion with the launch of a new BVA program at a premier cardiology facility in Southwest Ohio. This integration brings Daxor’s state-of-the-art testing to a high-volume heart failure care setting, targeting the growing market for chronic disease management.Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
OAK RIDGE, TN, March 26, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that new clinical data evaluating the accuracy of capillary leak detection scores compared to BVA was presented at the Society for Critical Care Medicine (SCCM) 2026 Critical Care Congress.Daxor CMO granted 5,941 company shares | DXR Insider Trading - Stock Titan
Daxor’s Chief Medical Officer John Jefferies acquired 5,941 shares via stock grants, including 3,656 vesting in 2029, lifting his direct holdings to 23,557 shares.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Daxor
Sign Up For FreeTo access detailed company insights
Founded in 1971, Daxor Corporation (NYSE: DXR) is the global leader in blood volume measurement technology focused on blood volume testing innovation.... Read More
